GB SCIENCES
GB Sciences (GBS) (OTC:GBLX) is a research and biotechnical development company setting the gold standard for manufacturing medical cannabis producing technology, as well as discovering, developing, and commercializing proprietary strains of cannabis to treat a broad range of serious medical conditions.
GB SCIENCES
Industry:
Biotechnology Cannabis Health Care Manufacturing Medical
Founded:
2001-04-04
Address:
Las Vegas, Nevada, United States
Country:
United States
Website Url:
http://www.gbsciences.com
Total Employee:
51+
Status:
Active
Contact:
866.721.0297
Email Addresses:
[email protected]
Total Funding:
2.02 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Aerogen
Aerogen is a medical device and drug delivery company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Praxis Precision Medicines
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.gbsciences.com
- Host name: dp-0ffe41d671.dreamhostps.com
- IP address: 173.236.155.18
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "GB Sciences"
GB Sciences - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +1 866-721-0297 GB Sciences is a research and biotechnical development company setting the โฆSee details»
Company Media Room of Gb Sciences
Press Release Oct 15, 2024 GB Sciences Signs Licensing Deal With EndoPure Life Sciences for 5% Gross Sales Royalty & Sponsorship of First-in-Human Trial for Their Cannabinoid-Based โฆSee details»
Finance - GB Sciences
Gb Sciences, Inc. (OTCQB:GBLX) GB Sciences, Inc. (OTCQB:GBLX) is a data-driven drug development company that leverages machine learning & high-throughput biology to transform โฆSee details»
GB Sciences, Inc | LinkedIn
GB Sciences, Inc. (OTCQB:GBLX) is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform plant-inspired drug โฆSee details»
GB Sciences (GBLX) Company Profile & Description - Stock Analysis
4 days ago GB Sciences, Inc., a plant-based research and biopharmaceutical drug development company. The company offers cannabis inspired medicines and complex therapeutic mixtures โฆSee details»
GB Sciences - Overview, News & Similar companies - ZoomInfo
GB Sciences contact info: Phone number: (866) 721-0297 Website: www.gbsciences.com What does GB Sciences do? GB Sciences is a plant based research and biopharmaceutical โฆSee details»
GB Sciences - Craft
Oct 29, 2024 GB Sciences has 1 employees across 2 locations and $3.12 m in annual revenue in FY 2020. See insights on GB Sciences including office locations, competitors, revenue, โฆSee details»
GB Sciences Launches Global Expansion in Canada with GBS
Mar 19, 2019 /CNW/ -- GB Sciences, Inc. (OTCQB: GBLX) today launched a global expansion strategy with the formation of GBS Global Biopharma Inc. ("GBS Global"), a...See details»
GBSciences 2025 Company Profile: Stock Performance & Earnings
GBSciences General Information Description. GB Sciences Inc is active in the healthcare sector. The company is engaged in developing and utilizing technologies in plant biology, cultivation, โฆSee details»
GB Sciences, Inc. Company Profile | Las Vegas, NV | Competitors ...
Find company research, competitor information, contact details & financial data for GB Sciences, Inc. of Las Vegas, NV. Get the latest business insights from Dun & Bradstreet.See details»
About GB SCIENCES INC | DxMultiomics
Gbsciences.com Mark Gb Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company creating patented, disease-targeted formulations of cannabis- and โฆSee details»
Successful 2022 Milestones Support Value of Gb Sciencesโ AI โฆ
Organization that will write the IND-application and run the first-in -human trials for our novel treatment for the motor symptoms of Parkinsonโs disease. Gb Sciences has four other โฆSee details»
Company GB Sciences, Inc. Börse Stuttgart - MarketScreener.com
Jul 9, 2024 GB Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company. It creates patented, disease-targeted formulations of cannabis and other plant โฆSee details»
GB Sciences, Inc. (GB Sciences, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ โฆ
May 7, 2025 Note: Although the Companyโs research and development activities are not illegal, the production and sale of cannabis products violate federal laws as they presently exist. โฆSee details»
Gb Sciences Leads Digital Transformation in Biopharma
Jul 18, 2022 Eighty percent of survey respondents (including 150 executives from large biopharma companies) said they believe that their organization needs to be more aggressive โฆSee details»
Home - GB Sciences
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern ...See details»
Gb Sciences' First-in-Class Parkinson's Disease Therapy ... - Newswire
Jul 11, 2023 To learn more about Gb Sciences, visit www.gbsciences.com. About Gb Sciences and GbS Global Biopharma. Gb Sciences, Inc. is a plant-inspired, biopharmaceutical research โฆSee details»
Successful 2022 Milestones Support Value of Gb Sciencesโ AI โฆ
Mar 10, 2023 To learn more about Gb Sciences, visit www.gbsciences.com. About Gb Sciences and GbS Global Biopharma Gb Sciences, Inc. is a plant-inspired, biopharmaceutical research โฆSee details»
GB Sciences Launches Global Expansion in Canada with GBS Global ...
Mar 19, 2019 866-721-0297, or Liz Bianco, Director of Publicity, [email protected]. Recent Posts. GB Sciences Co-Authors a Peer-Reviewed Article Showing that Heart Failure Can Be โฆSee details»
2020 - GB Sciences
GB Sciences Files Provisional Patent Application for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome (ARDS), the Leading Cause of Hospitalization and Deaths, โฆSee details»